Abstract
Purpose
Transscleral ocular iontophoresis has been proposed to deliver charged particulate drugs to ocular tissues effectively by transmitting a weak electrical current through the sclera. The electric fields formed are influenced by the electrode conditions, thus affecting the amount of particulate drugs delivered to the ocular tissues via iontophoresis. Computational simulation is widely used to simulate drug concentrations in the eye; therefore, reflecting the characteristics of the drugs in living tissues to the simulations is important for a more precise estimation of drug concentration. In this study, we investigated the effect of electrode conditions (location and size) on the efficacy of transscleral iontophoresis.
Methods
We first determined the simulation parameters based on the comparison of the amount of drug in the sclera in the simulation and in vivo experimental results. The injection of the negatively charged nanoparticles into the cul-de-sac of the lower eyelid was simulated. The active electrode (cathode) was attached to the skin immediately above the injection site, while the return electrode (anode) was placed over the eyebrow. The drug concentration distribution in the eye, based on either the location or size of each electrode, was evaluated using the finite element method with the estimated simulation parameters.
Results
Our results indicate that drug permeability varies depending on the location and the size of the electrodes.
Conclusion
Our findings demonstrate that the determination of optimal electrode conditions is necessary to enhance the effectiveness of transscleral iontophoresis.
Similar content being viewed by others
Data availability
Please contact the corresponding author (ich@hanyang.ac.kr) for data requests.
References
Järvinen K, Järvinen T, Urtti A. Ocular absorption following topical delivery. Adv Drug Deliv Rev. 1995;16(1):3–19.
Gote V, et al. Ocular drug delivery: present innovations and future challenges. J Pharmacol Exp Ther. 2019;370(3):602–24.
Waite D, et al. Posterior drug delivery via periocular route: challenges and opportunities. Therapeutic Delivery. 2017;8(8):685–99.
Eljarrat-Binstock E, Domb AJ. Iontophoresis: a non-invasive ocular drug delivery. J Controlled Release. 2006;110(3):479–89.
Güngör S, et al. Trans-scleral iontophoretic delivery of low molecular weight therapeutics. J Controlled Release. 2010;147(2):225–31.
Li SK, Hao J. Transscleral passive and iontophoretic transport: theory and analysis. Expert Opin Drug Deliv. 2018;15(3):283–99.
Eljarrat-Binstock E, et al. Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel. J Controlled Release. 2005;106(3):386–90.
Cohen AE, et al. Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis. Ophthalmology. 2012;119(1):66–73.
O’Neil EC, et al. Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial. Br J Ophthalmol. 2018;102(8):1011–3.
Bourne RR, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Global Health. 2017;5(9):e888–97.
Kim SH, et al. Transport barriers in transscleral drug delivery for retinal diseases. Ophthalmic Res. 2007;39(5):244–54.
Wang R et al. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances. J Drug Target, 2021: p. 1–35.
Luo L, et al. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis. J Controlled Release. 2019;296:68–80.
Qiu F, et al. Fenofibrate-loaded biodegradable nanoparticles for the treatment of experimental diabetic retinopathy and neovascular age-related macular degeneration. Mol Pharm. 2019;16(5):1958–70.
Faria P, Hallett M, Miranda PC. A finite element analysis of the effect of electrode area and inter-electrode distance on the spatial distribution of the current density in tDCS. J Neural Eng. 2011;8(6):066017.
Choi DS, Lee S. Optimizing electrode placement for transcranial direct current stimulation in nonsuperficial cortical regions: a computational modeling study. Biomed Eng Lett, 2023: p. 1–11.
Miranda PC, Faria P, Hallett M. What does the ratio of injected current to electrode area tell us about current density in the brain during tDCS? Clin Neurophysiol. 2009;120(6):1183–7.
Filipovic N, et al. Computational and experimental model of transdermal iontophorethic drug delivery system. Int J Pharm. 2017;533(2):383–8.
Bora DJ, Dasgupta R. Numerical simulation of iontophoresis for in-silico prediction of transdermal drugs in the dermal layers using skin impedance values. Volume 214. Computer Methods and Programs in Biomedicine; 2022. p. 106551.
Ciuculete DM, Morega AM. Numerical simulation of transdermal transport through iontophoresis. in 2015 E-Health and Bioengineering Conference (EHB). 2015. IEEE.
Naghipoor J, Jafary N, Rabczuk T. Mathematical and computational modeling of drug release from an ocular iontophoretic drug delivery device. Int J Heat Mass Transf. 2018;123:1035–49.
Missel PJ, Horner M, Muralikrishnan R. Simulating dissolution of intravitreal triamcinolone acetonide suspensions in an anatomically accurate rabbit eye model. Pharm Res. 2010;27(8):1530–46.
Srikantha N, et al. Influence of molecular shape, conformability, net surface charge, and tissue interaction on transscleral macromolecular diffusion. Exp Eye Res. 2012;102:85–92.
Kathawate J, Acharya S. Computational modeling of intravitreal drug delivery in the vitreous chamber with different vitreous substitutes. Int J Heat Mass Transf. 2008;51(23–24):5598–609.
Zhang F, Chen H, Huang Y. Computer modeling of drug delivery in the anterior human eye after subconjunctival and episcleral implantation. Comput Biol Med. 2017;89:162–9.
Lee S et al. In-vivo estimation of tissue electrical conductivities of a rabbit eye for precise simulation of electric field distributions during ocular iontophoresis. Int J Numer Methods Biomed Eng, 2021: p. e3540.
Thielscher A, Opitz A, Windhoff M. Impact of the gyral geometry on the electric field induced by transcranial magnetic stimulation. NeuroImage. 2011;54(1):234–43.
Kavousanakis ME, Kalogeropoulos NG, Hatziavramidis DT. Computational modeling of drug delivery to the posterior eye. Chem Eng Sci. 2014;108:203–12.
Mishima S, et al. Determination of tear volume and tear flow. Investig Ophthalmol Vis Sci. 1966;5(3):264–76.
Cu Y, Saltzman WM. Controlled surface modification with poly (ethylene) glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. Mol Pharm. 2009;6(1):173–81.
Missel PJ. Simulating intravitreal injections in anatomically accurate models for rabbit, monkey, and human eyes. Pharm Res. 2012;29(12):3251–72.
Lee S, et al. Individually customized transcranial temporal interference stimulation for focused modulation of deep brain structures: a simulation study with different head models. Sci Rep. 2020;10(1):1–11.
Lee C, et al. COMETS2: an advanced MATLAB toolbox for the numerical analysis of electric fields generated by transcranial direct current stimulation. J Neurosci Methods. 2017;277:56–62.
Reckow J, et al. Tolerability and blinding of 4x1 high-definition transcranial direct current stimulation (HD-tDCS) at two and three milliamps. Brain Stimul. 2018;11(5):991–7.
Kim S-N, et al. Iontophoretic delivery of dexamethasone-loaded nanoparticles to the anterior segment of the eye. J Ind Eng Chem. 2022;116:199–206.
Guler S, et al. Optimization of focality and direction in dense electrode array transcranial direct current stimulation (tDCS). J Neural Eng. 2016;13(3):036020.
Lee S, et al. Multi-channel transorbital electrical stimulation for effective stimulation of posterior retina. Sci Rep. 2021;11(1):1–11.
Haberbosch L, et al. Safety aspects, tolerability and modeling of retinofugal alternating current stimulation. Front NeuroSci. 2019;13:783.
Laakso I, et al. Inter-subject variability in electric fields of motor cortical tDCS. Brain Stimul. 2015;8(5):906–13.
Acknowledgements
This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT). (No. RS-2023-00266075).
Author information
Authors and Affiliations
Contributions
S.L. conceived the initial idea and wrote the manuscript. C.L. created the finite element model of the rabbit head model and conducted computational simulations. S.K. and YB.C. conducted rabbit experiments during ocular iontophoresis to measure drug concentrations in eyes. C.I. revised the manuscript. All authors revised and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lee, S., Kim, SN., Lee, C. et al. Multi-physics simulations for investigating the effect of electrode conditions on transscleral ocular iontophoresis for particulate drug delivery into ocular tissues. Biomed. Eng. Lett. 14, 439–450 (2024). https://doi.org/10.1007/s13534-024-00359-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13534-024-00359-2